@article{KhudairMarcuzziNgetal.2022,
  author    = {Khudair, Mohammed and Marcuzzi, Anna and Ng, Kwok and Tempest, Gavin Daniel and Bartoš, František and Peric, Ratko and Maier, Maximilian and Beccia, Flavia and Boccia, Stefania and Brandes, Mirko and Cardon, Greet and Carlin, Angela and Castagna, Carolina and Chaabene, Helmi and Chalkley, Anna and Ciaccioni, Simone and Cieślińska-Świder, Joanna and Čingienė, Vilma and Cortis, Cristina and Corvino, Chiara and de Geus, Eco J. C. and Di Baldassarre, Angela and Di Credico, Andrea and Drid, Patrik and Tarazaga, Rosa Ma Fern{\´a}ndez and Gall{\`e}, Francesca and S{\´a}nchez, Esther Garcia and Gebremariam, Mekdes and Ghinassi, Barbara and Goudas, Marios and Hayes, Grainne and Honorio, Samuel and Izzicupo, Pascal and Jahre, Henriette and Jelsma, Judith and Juric, Petra and Kolovelonis, Athanasios and Kongsvold, Atle and Kouidi, Evangelia and Mansergh, Fiona and Masanovic, Bojan and Mekonnen, Teferi and Mork, Paul Jarle and Murphy, Marie and O'Hara, Kelly and Torun, Ayse Ozbil and Palumbo, Federico and Popovic, Stevo and Prieske, Olaf and Puharic, Zrinka and Ribeiro, Jos{\´e} Carlos and Rumbold, Penny Louise Sheena and Sandu, Petru and Soric, Maroje and Stavnsbo, Mette and Syrmpas, Ioannis and van der Ploeg, Hidde P. and Van Hoye, Aur{\´e}lie and Vilela, Sofia and Woods, Catherine and Wunsch, Kathrin and Caprinica, Laura and MacDonncha, Ciaran and Ling, Fiona Chun Man},
  title     = {DE-PASS Best Evidence Statement (BESt): modifiable determinants of physical activity and sedentary behaviour in children and adolescents aged 5-19 years-a protocol for systematic review and meta-analysis},
  series = {BMJ open},
  volume    = {12},
  journal   = {BMJ open},
  number    = {9},
  publisher = {BMJ Publishing Group},
  address   = {London},
  organization    = {DE-PASS},
  issn      = {2044-6055},
  doi       = {10.1136/bmjopen-2021-059202},
  pages     = {8},
  year      = {2022},
  abstract  = {Introduction Physical activity among children and adolescents remains insufficient, despite the substantial efforts made by researchers and policymakers. Identifying and furthering our understanding of potential modifiable determinants of physical activity behaviour (PAB) and sedentary behaviour (SB) is crucial for the development of interventions that promote a shift from SB to PAB. The current protocol details the process through which a series of systematic literature reviews and meta-analyses (MAs) will be conducted to produce a best-evidence statement (BESt) and inform policymakers. The overall aim is to identify modifiable determinants that are associated with changes in PAB and SB in children and adolescents (aged 5-19 years) and to quantify their effect on, or association with, PAB/SB. Methods and analysis A search will be performed in MEDLINE, SportDiscus, Web of Science, PsychINFO and Cochrane Central Register of Controlled Trials. Randomised controlled trials (RCTs) and controlled trials (CTs) that investigate the effect of interventions on PAB/SB and longitudinal studies that investigate the associations between modifiable determinants and PAB/SB at multiple time points will be sought. Risk of bias assessments will be performed using adapted versions of Cochrane's RoB V.2.0 and ROBINS-I tools for RCTs and CTs, respectively, and an adapted version of the National Institute of Health's tool for longitudinal studies. Data will be synthesised narratively and, where possible, MAs will be performed using frequentist and Bayesian statistics. Modifiable determinants will be discussed considering the settings in which they were investigated and the PAB/SB measurement methods used. Ethics and dissemination No ethical approval is needed as no primary data will be collected. The findings will be disseminated in peer-reviewed publications and academic conferences where possible. The BESt will also be shared with policy makers within the DE-PASS consortium in the first instance. Systematic review registration CRD42021282874.},
  language  = {en}
}
@article{EhmannZollerMinichmayretal.2017,
  author    = {Ehmann, Lisa and Zoller, Michael and Minichmayr, Iris K. and Scharf, Christina and Maier, Barbara and Schmitt, Maximilian V. and Hartung, Niklas and Huisinga, Wilhelm and Vogeser, Michael and Frey, Lorenz and Zander, Johannes and Kloft, Charlotte},
  title     = {Role of renal function in risk assessment of target non-attainment after standard dosing of meropenem in critically ill patients},
  series = {Critical care},
  volume    = {21},
  journal   = {Critical care},
  publisher = {BioMed Central},
  address   = {London},
  issn      = {1466-609X},
  doi       = {10.1186/s13054-017-1829-4},
  pages     = {14},
  year      = {2017},
  abstract  = {Background: Severe bacterial infections remain a major challenge in intensive care units because of their high prevalence and mortality. Adequate antibiotic exposure has been associated with clinical success in critically ill patients. The objective of this study was to investigate the target attainment of standard meropenem dosing in a heterogeneous critically ill population, to quantify the impact of the full renal function spectrum on meropenem exposure and target attainment, and ultimately to translate the findings into a tool for practical application. Methods: A prospective observational single-centre study was performed with critically ill patients with severe infections receiving standard dosing of meropenem. Serial blood samples were drawn over 4 study days to determine meropenem serum concentrations. Renal function was assessed by creatinine clearance according to the Cockcroft and Gault equation (CLCRCG). Variability in meropenem serum concentrations was quantified at the middle and end of each monitored dosing interval. The attainment of two pharmacokinetic/pharmacodynamic targets (100\% T->MIC, 50\% T->4xMIC) was evaluated for minimum inhibitory concentration (MIC) values of 2 mg/L and 8 mg/L and standard meropenem dosing (1000 mg, 30-minute infusion, every 8 h). Furthermore, we assessed the impact of CLCRCG on meropenem concentrations and target attainment and developed a tool for risk assessment of target non-attainment. Results: Large inter-and intra-patient variability in meropenem concentrations was observed in the critically ill population (n = 48). Attainment of the target 100\% T->MIC was merely 48.4\% and 20.6\%, given MIC values of 2 mg/L and 8 mg/L, respectively, and similar for the target 50\% T->4xMIC. A hyperbolic relationship between CLCRCG (25-255 ml/minute) and meropenem serum concentrations at the end of the dosing interval (C-8h) was derived. For infections with pathogens of MIC 2 mg/L, mild renal impairment up to augmented renal function was identified as a risk factor for target non-attainment (for MIC 8 mg/L, additionally, moderate renal impairment). Conclusions: The investigated standard meropenem dosing regimen appeared to result in insufficient meropenem exposure in a considerable fraction of critically ill patients. An easy-and free-to-use tool (the MeroRisk Calculator) for assessing the risk of target non-attainment for a given renal function and MIC value was developed.},
  language  = {en}
}